[FREE Report] 5 Growth Stocks Under $49
Stay focused on the long-term with these 5 growth stock picks.
Learn More.
William J. Febbo, insider at OptimizeRx
William J. Febbo Insider Alerts

Get notified the next time William J. Febbo buys or sells OptimizeRx stock. Enter your email address below to get our daily insider buying and selling report.

William J. Febbo Insider Information

CEO of OptimizeRx
Over the last 20 years, Will has led health service, technology and finance companies, connecting key participants in the healthcare industry. As CEO and Director of OptimizeRx, he has continued to drive innovation in healthcare, and over the last several years, he has led the transformation of OptimizeRx into a leading digital health company that facilitates communication at the point-of-care for better health outcomes.

In 1999, Will co-founded and became CEO of MedPanel, a market intelligence and communication provider to the life sciences and financial industries. MedPanel was acquired in 2007 by Merriman Capital, a leading investment bank. At Merriman, he served as COO of investment banking and CEO of the firm’s Digital Capital Network. He launched pioneering digital compliance and transparency products and was part of the management team that raised more than $500 million in banking and M&A transactions.

Will earlier held a number of M&A and international business development roles at multinational companies involved in automotive, medical, precious metals and other industries.  

He currently serves as a faculty member for Massachusetts Institute of Technology’s linQ program, a collaborative initiative increasing the potential of innovative biomedical research to benefit society and the economy.

Will serves on board of The United Nations of Greater Boston, a non-profit focused on building a stronger network of global citizens in the Boston area. He also serves as a board member of Modular Medical, an early stage public medical device company. 

Will earned his Bachelor of Arts in International Studies and Spanish from Dickinson College, Pennsylvania. He is fluent in Spanish, married with three children and enjoys playing soccer.

What is William J. Febbo's net worth?

The estimated net worth of William J. Febbo is at least $12.52 million as of March 25th, 2021. Mr. Febbo owns 273,278 shares of OptimizeRx stock worth more than $12,521,598 as of January 20th. This net worth evaluation does not reflect any other assets that Mr. Febbo may own. Learn More.

What is William J. Febbo's salary?

As the CEO of OptimizeRx Co., Mr. Febbo earned a total compensation package of $833,990.00 in 2019. Mr. Febbo earned a salary of $300,000.00, a bonus of $126,990.00, stock awards of $391,800.00, and other compensation of $15,200.00.

How do I contact William J. Febbo?

The corporate mailing address for Mr. Febbo and other OptimizeRx executives is 400 WATER STREET SUITE 200, ROCHESTER MI, 48307. OptimizeRx can also be reached via phone at (248) 651-6568 and via email at [email protected]

Has William J. Febbo been buying or selling shares of OptimizeRx?

William J. Febbo has not been actively trading shares of OptimizeRx over the course of the past ninety days. Most recently, William J. Febbo sold 16,666 shares of the business's stock in a transaction on Wednesday, December 15th. The shares were sold at an average price of $54.55, for a transaction totalling $909,130.30.

Who are OptimizeRx's active insiders?

OptimizeRx's insider roster includes Douglas Baker (CFO), William Febbo (CEO), Miriam Paramore (Insider), and Stephen Silvestro (Insider).

Are insiders buying or selling shares of OptimizeRx?

During the last twelve months, insiders at the sold shares 35 times. They sold a total of 460,064 shares worth more than $27,570,342.42. The most recent insider tranaction occured on December, 17th when insider Stephen L Silvestro sold 13,241 shares worth more than $726,533.67. Insiders at OptimizeRx own 6.5 % of the company.

Information on this page was last updated on 12/17/2021.

William J. Febbo Insider Trading History at OptimizeRx

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/15/2021Sell16,666$54.55$909,130.30View SEC Filing Icon  
11/15/2021Sell16,666$82.18$1,369,611.88View SEC Filing Icon  
10/15/2021Sell16,666$84.20$1,403,277.20View SEC Filing Icon  
3/25/2021Sell80,000$46.10$3,688,000.00273,278View SEC Filing Icon  
11/6/2019Buy5,000$10.38$51,900.00
12/19/2018Buy2,000$9.94$19,880.00View SEC Filing Icon  
11/7/2018Buy600$16.32$9,792.00View SEC Filing Icon  
6/22/2018Buy1,000$10.50$10,500.00View SEC Filing Icon  
12/1/2016Buy4,000$0.85$3,400.0044,000View SEC Filing Icon  
11/10/2016Buy9,000$0.90$8,100.0040,000View SEC Filing Icon  
6/9/2016Buy21,567$1.08$23,292.3619,433View SEC Filing Icon  
See Full Table

William J. Febbo Buying and Selling Activity at OptimizeRx

This chart shows William J Febbo's buying and selling at OptimizeRx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

OptimizeRx Company Overview

OptimizeRx logo
OptimizeRx Corp. is digital health company, which engages in the provision of digital health messaging via electronic health records, which serves as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging; and brand support. The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Rochester, MI.
Read More

Today's Range

Now: $45.82
Low: $44.93
High: $46.69

50 Day Range

MA: $61.39
Low: $45.82
High: $87.22

2 Week Range

Now: $45.82
Low: $39.06
High: $99.18

Volume

465,246 shs

Average Volume

290,904 shs

Market Capitalization

$814.22 million

P/E Ratio

327.29

Dividend Yield

N/A

Beta

0.55
5 Free Dividend Stocks for 2022
Could these top payout stocks be part of the greatest wealth-creating tool in history?
Learn More.